Annual | 12/2023FY | 12/2024FY |
---|---|---|
Total Revenue | $36.12 B | $37.7 B |
Net Income | $18.42 B | $6.13 B |
Quarterly | 6/30/2023 | 9/30/2023 |
Total Assets | $75.6 B | $74.29 B |
Total Liabilities | $58.88 B | $58.91 B |
Operating Margin | 23.50% | 27.54% |
Gsk Plc
980 Great West Road |
|
Industry | Pharmaceuticals: Major |
---|---|
Sector | Health Technology |
Employees | 70,212 |
Ms. Emma N. Walmsley | Ms. Julie Brown | Mr. Timothy Woodthorpe | ||||||||||||||||||||||
Chief Executive Officer & Executive Director | Chief Financial Officer & Executive Director | Group Treasurer & Senior Vice President | ||||||||||||||||||||||
Ms. Shobie Ramakrishnan | Dr. Tony Wood | Ms. Amy Altshul | Dr. Harry C. Dietz | Ms. Wendy Becker | Dr. Jeannie T. Lee | Dr. Vishal Sikka | Dr. Vishal Sikka | Ms. Emma N. Walmsley | Mr. Urs Rohner | Mr. Urs Rohner | Dr. Jesse L. Goodman | Dr. Jesse L. Goodman | Dr. Hal V. Barron | Ms. Elizabeth McKee Anderson | Ms. Elizabeth McKee Anderson | Ms. Julie Brown | Mr. Jonathan Richard Symonds | Mr. Charles A. Bancroft | Mr. Charles A. Bancroft | Dr. Anne C. Beal | Dr. Anne C. Beal | Dr. Harry C. Dietz | Ms. Victoria A. Whyte | |
Chief Digital & Technology Officer | Chief Scientific Officer | SVP-Legal, Research & Development | Independent Non-Executive Director | Non-Executive Director | Non-Executive Director | Independent Non-Executive Director | Independent Non-Executive Director | Chief Executive Officer & Executive Director | Independent Non-Executive Director | Independent Non-Executive Director | Independent Non-Executive Director | Independent Non-Executive Director | Non-Independent Non-Executive Director | Independent Non-Executive Director | Independent Non-Executive Director | Chief Financial Officer & Executive Director | Non-Executive Chairman | Senior Independent Non-Executive Director | Senior Independent Non-Executive Director | Independent Non-Executive Director | Independent Non-Executive Director | Independent Non-Executive Director | Secretary |
Company Name | Price | EPS (FY) | Annual Dividend | Book Value (FY) | Cash Flow (FY) |
---|---|---|---|---|---|
Gsk Plc | $42.87 | 3.03 | 1.44 | 8.39 | 4.41 |